Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
how it runs
Come on, let's take off
pacritinib sales will be strong!
the drug is used after ruxolitinib...
Why is everything stopped? At least it seems
https://clinicaltrials.gov/ct2/show/NCT04858256?cond=pacritinib&draw=2&rank=1
https://www.ldmicro.com/profile/tmdi/insiders
G.Vance and the others no
2022-07-12 13G/A BIOTECHNOLOGY VALUE FUND L P 4,565,242 8,748,629 +91.64
https://fintel.io/so/us/axsm/morgan-stanley
who despises buys
https://www.streetinsider.com/Analyst+PT+Change/Axsome+Therapeutics+%28AXSM%29+PT+Raised+to+%2454+at+Morgan+Stanley/20304472.html
Morgan Stanley Upgrade to 54
they were the lowest ones
https://www.utsouthwestern.edu/newsroom/articles/year-2022/june-rapid-covid-test.html
these tests for biosurvallance are interesting
Well, we are in luck!
The bigger the challenge, the bigger the triumph!
Can't wait for Gary to do something to make himself loved!
Huh
7
Yeah!
https://www.marketbeat.com/stocks/NASDAQ/EPIX/institutional-ownership/
https://www.morningstar.com/stocks/xnas/epix/ownership
Found
Total (for Top 20) 33.21 14,630,814
Institution
Total (for Top 20) 79.50 35,025,554
Mmmm
took a bit at 0.7
Dr. Usman continued, “As we previously indicated, the Board and the Company are actively controlling the Company’s expenses while seeking to monetize its remaining assets. And while we welcome the opportunity to further demonstrate the propriety of our actions in court, we (and all the many stockholders with whom we have spoken) would prefer for JDS1 to drop its lawsuit and proxy contest, both of which are depleting the resources of the Company. The Board remains committed to distributing its cash, net of liabilities and obligations, expeditiously to stockholders once the potential liabilities and expenses associated with the stockholder litigation and the proxy contest are known.”
So, JDS1 stop, please please please!
they sell everything!
what is left is likely to be worth little so let's get moving!
I finished uploading 2.64 last purchase
fingers crossed... for after the summer
MC 77 mil
imo He wanted to do some other development suggested by Arnold but when it's too much it's too much!
During a call with investors regarding the CEO transition, interim Chief Executive Paul Cataford said that Titan's board of directors met three times in the weeks following the release of the company's third quarter results. During these meetings, the board decided the company needed to move forward under new leadership.
Ergo they kicked him (McNally) out
So the second quarter is closed! We will have a more realistic sales projection!
I imagine Robocop busy presenting them, always interesting how he frames things!
For the rest it seems to me that everything has stopped!
So something comes to me
Axsome is also working with the FDA to resolve chemistry, manufacturing, and controls issues with its regulatory submission for approval of AXS-07 in treating migraine. The company believes the issues are addressable and anticipates "an expeditious resubmission" of the New Drug Application.
Will it happen before AXS-05 is approved or after?
In my opinion first!
in TRIL, after entering, the stock sketch at 29/30, if I remember correctly, then someone started selling! I wonder who was interested? they bring it to 5 and then they did BO
if the studies give us good news...
someone buys
https://fintel.io/n/us/cbio
How strange here!
I feel a bit vulture but bull ... sorry for those who are higher entrance!
I hope they manage to sell everything there doesn't seem to be any other future here! quickly
IMO It has nothing to do with TMDI!
I still have a fever... I have to cancel the BOOM
but it is on the list
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=S&l=50&co1=AND&d=PTXT&s1=%22titan+medical%22&Query=%22titan+medical%22
https://www.nasdaq.com/articles/got-%24500-3-absurdly-cheap-healthcare-stocks-that-are-set-to-skyrocket
https://fintel.io/sst/us/axsm
Lots of sales on Friday! many S and few M.
Put some cash here for your retirement
https://fintel.io/so/us/axsm
I add!
Shhhhhhhhh
how sad!
they spend too much
Let's see if G Vance buys some share to celebrate his leadership
it would be appreciable
https://www.catalystbiosciences.com/partnering-opportunities/
This remains to be sold
SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its intention to distribute cash to the Company’s stockholders through one or more distributions. The intention of the Company’s Board of Directors (the “Board”) is to maximize the size of the total distribution after satisfying or reserving for Company obligations, and to complete the distribution as soon as practicable. The Board currently expects the total amount of cash to be distributed to stockholders to be as much as $65 million, depending upon several factors, including pending stockholder litigation.
“After careful deliberation by the Board and constructive engagement with several of the Company’s largest investors, I am pleased to announce that we are planning to distribute cash to stockholders,” said Nassim Usman, Ph.D., Chief Executive Officer of Catalyst Biosciences. “This follows our recently completed sale of a portion of our product portfolio for up to $60 million in cash, $55 million upfront and $5 million in a 12-month hold-back, after a thorough and competitive process with the assistance of independent financial and legal advisors.”
who knows what McNally thinks of the new CEO?
I guess G.Vance gave the ok because the pain period is about to end and they will have two or three pills to make you feel better!
If I were someone who ran short I would hope for a dilution ..
Even assuming they will do a capital increase in your opinion when they do: before or after declaration of approval?
Cover before it's too late!
https://fintel.io/sst/us/axsm
reminds me of somaxon pharma somx ...
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022036s000ltr.pdf
something makes me think of a BO